MediSix Therapeutics
Manufacturing · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11 Biopolis Way Helios 05-08/09, Singapo...Phone Number
(617) 686-3640Website
www.medisixtx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About MediSix Therapeutics
MediSix Therapeutics specializes in developing innovative T-cell therapies aimed at transforming the treatment of cancer and autoimmune diseases. Founded by Professor Dario Campana in 2016, the company leverages proprietary technologies, including their unique PEBL solution, to enhance T-cell function and address challenges in CAR T-cell therapy. Their robust research pipeline focuses on complex and rare T-cell malignancies, targeting patients in need of advanced therapeutic options. The company is headquartered in Singapore and is led by a team of experienced professionals in the biomedical and pharmaceutical industries.Explore more
MediSix Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is MediSix Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at MediSix Therapeutics
Check out if MediSix Therapeutics is spiking on competitors!
Product Launch: Get notified when MediSix Therapeutics launches new products
Check if MediSix Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if MediSix Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on MediSix Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once MediSix Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
MediSix Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined MediSix Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to MediSix Therapeutics
Compare insights from companies similar to MediSix Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
MediSix Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
MediSix Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about MediSix Therapeutics.
MediSix Therapeutics Tech Stack
A closer look at the technologies used by MediSix Therapeutics
MediSix Therapeutics News & Media
Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MediSix Therapeutics, a cell therapy company creating novel therapeutics to target T-cell leukemia and lymphoma, today announced a collaboration to discover novel antibodies against five undisclosed targets. Under the terms of the collaboration, Twist will leverage its proprietary Library ofForm D Friday: GV, Wellington invest in local biotech startups
Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding MediSix Therapeutics
Sign Up For FreeTo access detailed company insights
MediSix Therapeutics specializes in developing innovative T-cell therapies aimed at transforming the treatment of cancer and autoimmune diseases. Founded by Professor Dario Campana in 2016, the company leverages proprietary technologies, including their unique PEBL solution, to enhance T-cell function and address challenges in CAR T-cell therapy. T... Read More
